Fundraising Fox
Chiimatherapeutics
Founded 2021 · 2 employees on LinkedIn · 1 known investors
Find your way into Chiimatherapeutics
Sign up to see every warm intro you have to Chiimatherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chiimatherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Chiima Therapeutics is a biotech company developing first-in-class, non-hormonal therapies for women's health conditions with unmet needs, including endometriosis, pre-term labor, and PCOS. Its pipeline covers investigational compounds addressing diseases that affect women worldwide.
Investors · 1
Related companies · 2
Kymera TherapeuticsKymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins. The company focuses on advancing small molecule therapies designed to address critical health problems across multiple disease areas.
KimiaKimia is a therapeutics company developing new drugs through its ATLAS platform, working with partners in the pharmaceutical and biotechnology industries. It focuses on improving outcomes for patients.
Companies working in the same space as Chiimatherapeutics.
Frequently asked questions
- What does Chiimatherapeutics do?
- Chiima Therapeutics is a biotech company developing first-in-class, non-hormonal therapies for women's health conditions with unmet needs, including endometriosis, pre-term labor, and PCOS. Its pipeline covers investigational compounds addressing diseases that affect women worldwide.
- Who are Chiimatherapeutics's investors?
- Chiimatherapeutics's investors include The Innovation Space.